When was Laboratoire Sterop - Stockage founded?

Laboratoire Sterop - Stockage was founded on 01 Jan 1971, making it 55 years old.

Is Laboratoire Sterop - Stockage still active?

Yes, Laboratoire Sterop - Stockage is currently active.

Where is Laboratoire Sterop - Stockage registered?

Laboratoire Sterop - Stockage's registered address is Avenue de Scheut 46-50, 1070 Anderlecht, Belgium.

How many employees does Laboratoire Sterop - Stockage have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), Laboratoire Sterop - Stockage reported 101.5 full-time equivalent employees.

What is Laboratoire Sterop - Stockage's annual turnover?

Laboratoire Sterop - Stockage's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €17,345,927.

Did Laboratoire Sterop - Stockage make a profit or a loss?

Laboratoire Sterop - Stockage's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a loss of €529,412.

When did Laboratoire Sterop - Stockage last file annual accounts?

Laboratoire Sterop - Stockage's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is Laboratoire Sterop - Stockage B Corp certified?

We have no B Corp certification on file for Laboratoire Sterop - Stockage.

Does Laboratoire Sterop - Stockage hold Fairtrade certification?

No, Laboratoire Sterop - Stockage does not currently hold Fairtrade certification.

Laboratoire Sterop - Stockage

Q: What does Laboratoire Sterop - Stockage do?

Laboratoire Sterop - Stockage's registered main activities are Manufacture of medicaments, Manufacture of other chemical products n.e.c., Production of salicylic and o-acetylsalicylic acid, Activities of agents involved in non-specialised wholesale, and Warehousing and storage.

BE 0408.238.752

Copied!

NV/SA

Status

Active

Founded

01 Jan 1971 · 55 yrs

Size

Medium · 101.5 FTE

Legal name

Laboratoires Sterop

Main activity

Manufacture of medicaments

Activities

5 activities

Manufacture of medicamentsManufacture of other chemical products n.e.c.Production of salicylic and o-acetylsalicylic acidActivities of agents involved in non-specialised wholesaleWarehousing and storage

Financials

Turnover2025

€17.3M+11.3%

Profit / Loss2025

−€529K-155.9%

Equity2025

€8M+8.6%

2025	2024	2023	2022
€17,345,927+11.3%	€15,588,102+0.5%	€15,507,574+31.1%	€11,832,314
-€529,412-155.9%	€947,384-4.2%	€988,571>1000%	€69,078
€8,032,650+8.6%	€7,400,189+2.8%	€7,202,059+0.1%	€7,193,488
€15,861,076+38.1%	€11,487,129+25.6%	€9,147,064+148.2%	€3,685,532
€2,037,902+503.7%	€337,597-46.8%	€634,247+27.8%	€496,439
101.5+11.1%	91.4+1.4%	90.1+10.7%	81.4
€170,896+0.2%	€170,548-0.9%	€172,115+18.4%	€145,360

Frequently asked questions

01What is Laboratoire Sterop - Stockage's official registered name?

Laboratoires Sterop.

02What is Laboratoire Sterop - Stockage's enterprise number (VAT number)?

BE 0408.238.752.

03What is Laboratoire Sterop - Stockage's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

Financial statements

	2025	2024	2023	2022
Income statement
	€17,345,927+11.3%	€15,588,102+0.5%	€15,507,574+31.1%	€11,832,314
	101.5+11.1%	91.4+1.4%	90.1+10.7%	81.4
	€170,896+0.2%	€170,548-0.9%	€172,115+18.4%	€145,360
	€6,420,316+13.5%	€5,658,098+4.4%	€5,422,022+17.4%	€4,619,405
	-€266,583-119%	€1,405,306+1.5%	€1,385,179>1000%	€116,654
	€490,464	—	—	—
	€263,634	—	—	—
	-€529,412-155.9%	€947,384-4.2%	€988,571>1000%	€69,078
	€263,703+34.7%	€195,820-10.6%	€218,978+69.4%	€129,291
Profitability
	2.8%	—	—	—
	-3.1%-150.2%	6.1%-4.7%	6.4%+991.9%	0.6%
	-6.6%-151.5%	12.8%-6.7%	13.7%>1000%	1.0%
	-2.2%-144.1%	5.0%-17%	6.0%+852.3%	0.6%
Solvency
	€23,929,726+26.7%	€18,887,317+15.5%	€16,349,123+50.3%	€10,879,020
	€8,219,558+69.7%	€4,843,212-1.6%	€4,924,367+135%	€2,095,414
	€3,141,693+5.2%	€2,985,304+6%	€2,815,3040%	€2,815,304
	€8,032,650+8.6%	€7,400,189+2.8%	€7,202,059+0.1%	€7,193,488
	33.6%-14.3%	39.2%-11.1%	44.1%-33.4%	66.1%
	€9,395,145+782.3%	€1,064,827-9.3%	€1,173,863>1000%	€34,300
	1.17+712.9%	0.14-11.7%	0.16>1000%	0.00
	€15,861,076+38.1%	€11,487,129+25.6%	€9,147,064+148.2%	€3,685,532
	1.97+27.2%	1.55+22.2%	1.27+147.9%	0.51
	-0.72-107.1%	10.05-90.4%	104.17+258.9%	29.02
Liquidity
	€2,037,902+503.7%	€337,597-46.8%	€634,247+27.8%	€496,439
	€3,503,538+15.8%	€3,025,214+35.9%	€2,226,131+28.8%	€1,729,035
	€5,888,076-14.8%	€6,907,775+35%	€5,116,492+48.8%	€3,438,779
	€3,326,528-41.4%	€5,672,752+62.1%	€3,500,287+69%	€2,071,210
	€6,206,980-40.2%	€10,380,438+30.4%	€7,960,915+118%	€3,651,232
	1.62+58.7%	1.02+3.5%	0.98-33.3%	1.48
	€6,029,945>1000%	€536,440+5.5%	€508,731-77.2%	€2,233,902
Efficiency
	124 days-23.4%	162 days+34.3%	120 days+13.5%	106 days
	115 days-46.6%	216 days+46.6%	147 days+32.4%	111 days
	195 days+3.4%	189 days+17.3%	161 days-12.2%	183 days
	2.00-10.3%	2.23-12.5%	2.55+25.6%	2.03
Profit appropriation
	€375,000-60.1%	€940,000-4.1%	€980,000	—
	€2,908,869+16.1%	€2,505,2210%	€2,505,2210%	€2,505,221
	€505,547-16.3%	€604,223+1.2%	€596,839+1.5%	€588,268

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€17,345,927+11.3%	€15,588,102+0.5%	€15,507,574+31.1%	€11,832,314
	101.5+11.1%	91.4+1.4%	90.1+10.7%	81.4
	€170,896+0.2%	€170,548-0.9%	€172,115+18.4%	€145,360
	€6,420,316+13.5%	€5,658,098+4.4%	€5,422,022+17.4%	€4,619,405
	-€266,583-119%	€1,405,306+1.5%	€1,385,179>1000%	€116,654
	€490,464	—	—	—
	€263,634	—	—	—
	-€529,412-155.9%	€947,384-4.2%	€988,571>1000%	€69,078
	€263,703+34.7%	€195,820-10.6%	€218,978+69.4%	€129,291
Profitability
	2.8%	—	—	—
	-3.1%-150.2%	6.1%-4.7%	6.4%+991.9%	0.6%
	-6.6%-151.5%	12.8%-6.7%	13.7%>1000%	1.0%
	-2.2%-144.1%	5.0%-17%	6.0%+852.3%	0.6%
Solvency
	€23,929,726+26.7%	€18,887,317+15.5%	€16,349,123+50.3%	€10,879,020
	€8,219,558+69.7%	€4,843,212-1.6%	€4,924,367+135%	€2,095,414
	€3,141,693+5.2%	€2,985,304+6%	€2,815,3040%	€2,815,304
	€8,032,650+8.6%	€7,400,189+2.8%	€7,202,059+0.1%	€7,193,488
	33.6%-14.3%	39.2%-11.1%	44.1%-33.4%	66.1%
	€9,395,145+782.3%	€1,064,827-9.3%	€1,173,863>1000%	€34,300
	1.17+712.9%	0.14-11.7%	0.16>1000%	0.00
	€15,861,076+38.1%	€11,487,129+25.6%	€9,147,064+148.2%	€3,685,532
	1.97+27.2%	1.55+22.2%	1.27+147.9%	0.51
	-0.72-107.1%	10.05-90.4%	104.17+258.9%	29.02
Liquidity
	€2,037,902+503.7%	€337,597-46.8%	€634,247+27.8%	€496,439
	€3,503,538+15.8%	€3,025,214+35.9%	€2,226,131+28.8%	€1,729,035
	€5,888,076-14.8%	€6,907,775+35%	€5,116,492+48.8%	€3,438,779
	€3,326,528-41.4%	€5,672,752+62.1%	€3,500,287+69%	€2,071,210
	€6,206,980-40.2%	€10,380,438+30.4%	€7,960,915+118%	€3,651,232
	1.62+58.7%	1.02+3.5%	0.98-33.3%	1.48
	€6,029,945>1000%	€536,440+5.5%	€508,731-77.2%	€2,233,902
Efficiency
	124 days-23.4%	162 days+34.3%	120 days+13.5%	106 days
	115 days-46.6%	216 days+46.6%	147 days+32.4%	111 days
	195 days+3.4%	189 days+17.3%	161 days-12.2%	183 days
	2.00-10.3%	2.23-12.5%	2.55+25.6%	2.03
Profit appropriation
	€375,000-60.1%	€940,000-4.1%	€980,000	—
	€2,908,869+16.1%	€2,505,2210%	€2,505,2210%	€2,505,221
	€505,547-16.3%	€604,223+1.2%	€596,839+1.5%	€588,268

2025

2024

2023

2022

Income statement

€17,345,927+11.3%

€15,588,102+0.5%

€15,507,574+31.1%

€11,832,314

101.5+11.1%

91.4+1.4%

90.1+10.7%

81.4

€170,896+0.2%

€170,548-0.9%

€172,115+18.4%

€145,360

€6,420,316+13.5%

€5,658,098+4.4%

€5,422,022+17.4%

€4,619,405

-€266,583-119%

€1,405,306+1.5%

€1,385,179>1000%

€116,654

€490,464

—

€263,634

—

-€529,412-155.9%

€947,384-4.2%

€988,571>1000%

€69,078

€263,703+34.7%

€195,820-10.6%

€218,978+69.4%

€129,291

Profitability

2.8%

—

-3.1%-150.2%

6.1%-4.7%

6.4%+991.9%

0.6%

-6.6%-151.5%

12.8%-6.7%

13.7%>1000%

1.0%

-2.2%-144.1%

5.0%-17%

6.0%+852.3%

0.6%

Solvency

€23,929,726+26.7%

€18,887,317+15.5%

€16,349,123+50.3%

€10,879,020

€8,219,558+69.7%

€4,843,212-1.6%

€4,924,367+135%

€2,095,414

€3,141,693+5.2%

€2,985,304+6%

€2,815,3040%

€2,815,304

€8,032,650+8.6%

€7,400,189+2.8%

€7,202,059+0.1%

€7,193,488

33.6%-14.3%

39.2%-11.1%

44.1%-33.4%

66.1%

€9,395,145+782.3%

€1,064,827-9.3%

€1,173,863>1000%

€34,300

1.17+712.9%

0.14-11.7%

0.16>1000%

0.00

€15,861,076+38.1%

€11,487,129+25.6%

€9,147,064+148.2%

€3,685,532

1.97+27.2%

1.55+22.2%

1.27+147.9%

0.51

-0.72-107.1%

10.05-90.4%

104.17+258.9%

29.02

Liquidity

€2,037,902+503.7%

€337,597-46.8%

€634,247+27.8%

€496,439

€3,503,538+15.8%

€3,025,214+35.9%

€2,226,131+28.8%

€1,729,035

€5,888,076-14.8%

€6,907,775+35%

€5,116,492+48.8%

€3,438,779

€3,326,528-41.4%

€5,672,752+62.1%

€3,500,287+69%

€2,071,210

€6,206,980-40.2%

€10,380,438+30.4%

€7,960,915+118%

€3,651,232

1.62+58.7%

1.02+3.5%

0.98-33.3%

1.48

€6,029,945>1000%

€536,440+5.5%

€508,731-77.2%

€2,233,902

Efficiency

124 days-23.4%

162 days+34.3%

120 days+13.5%

106 days

115 days-46.6%

216 days+46.6%

147 days+32.4%

111 days

195 days+3.4%

189 days+17.3%

161 days-12.2%

183 days

2.00-10.3%

2.23-12.5%

2.55+25.6%

2.03

Profit appropriation

€375,000-60.1%

€940,000-4.1%

€980,000

—

€2,908,869+16.1%

€2,505,2210%

€2,505,221

€505,547-16.3%

€604,223+1.2%

€596,839+1.5%

€588,268

Laboratoire Sterop - Stockage

Activities

Financials

Frequently asked questions

All locations

Financial statements

All locations

Financial statements